Review



disitamab vedotin aidixi  (RemeGen Ltd)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    RemeGen Ltd disitamab vedotin aidixi
    Summary of clinically approved ADCs.
    Disitamab Vedotin Aidixi, supplied by RemeGen Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/disitamab vedotin aidixi/product/RemeGen Ltd
    Average 90 stars, based on 1 article reviews
    disitamab vedotin aidixi - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Resistance to antibody–drug conjugates: A review"

    Article Title: Resistance to antibody–drug conjugates: A review

    Journal: Acta Pharmaceutica Sinica. B

    doi: 10.1016/j.apsb.2024.12.036

    Summary of clinically approved ADCs.
    Figure Legend Snippet: Summary of clinically approved ADCs.

    Techniques Used:



    Similar Products

    disitamab vedotin aidixi  (RemeGen Ltd)
    90
    RemeGen Ltd disitamab vedotin aidixi
    Summary of clinically approved ADCs.
    Disitamab Vedotin Aidixi, supplied by RemeGen Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/disitamab vedotin aidixi/product/RemeGen Ltd
    Average 90 stars, based on 1 article reviews
    disitamab vedotin aidixi - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    disitamab vedotin (aidixi  (RemeGen Ltd)
    90
    RemeGen Ltd disitamab vedotin (aidixi
    Summary of clinically approved ADCs.
    Disitamab Vedotin (Aidixi, supplied by RemeGen Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/disitamab vedotin (aidixi/product/RemeGen Ltd
    Average 90 stars, based on 1 article reviews
    disitamab vedotin (aidixi - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    disitamab vedotin/aidixi  (RemeGen Ltd)
    90
    RemeGen Ltd disitamab vedotin/aidixi
    Information on ADC products approved by the FDA or other regulatory agencies.
    Disitamab Vedotin/Aidixi, supplied by RemeGen Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/disitamab vedotin/aidixi/product/RemeGen Ltd
    Average 90 stars, based on 1 article reviews
    disitamab vedotin/aidixi - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    disitamab vedotin (aidixi)  (RemeGen Ltd)
    90
    RemeGen Ltd disitamab vedotin (aidixi)
    Overview of FDA-approved ADC drugs
    Disitamab Vedotin (Aidixi), supplied by RemeGen Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/disitamab vedotin (aidixi)/product/RemeGen Ltd
    Average 90 stars, based on 1 article reviews
    disitamab vedotin (aidixi) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of clinically approved ADCs.

    Journal: Acta Pharmaceutica Sinica. B

    Article Title: Resistance to antibody–drug conjugates: A review

    doi: 10.1016/j.apsb.2024.12.036

    Figure Lengend Snippet: Summary of clinically approved ADCs.

    Article Snippet: Disitamab vedotin , Aidixi® , RemeGen , HER2 , mc-VC-PABC , MMAE , 4 , 2021 , GC, UC , Hematologic toxicity , – .

    Techniques:

    Information on ADC products approved by the FDA or other regulatory agencies.

    Journal: Bioengineering & Translational Medicine

    Article Title: Antibody drug conjugates in the clinic

    doi: 10.1002/btm2.10677

    Figure Lengend Snippet: Information on ADC products approved by the FDA or other regulatory agencies.

    Article Snippet: Disitamab vedotin/Aidixi® (RemeGen) , MMAE (Auristatin), Microtubule inhibitor , Enzyme cleavable , HER2 , IgG1 , Locally advanced or metastatic gastric cancer , NMPA (2021).

    Techniques: Recombinant

    Representative active clinical trials for approved ADCs.

    Journal: Bioengineering & Translational Medicine

    Article Title: Antibody drug conjugates in the clinic

    doi: 10.1002/btm2.10677

    Figure Lengend Snippet: Representative active clinical trials for approved ADCs.

    Article Snippet: Disitamab vedotin/Aidixi® (RemeGen) , MMAE (Auristatin), Microtubule inhibitor , Enzyme cleavable , HER2 , IgG1 , Locally advanced or metastatic gastric cancer , NMPA (2021).

    Techniques: Clinical Proteomics, Transformation Assay, Mutagenesis, Biomarker Discovery

    Overview of FDA-approved ADC drugs

    Journal: Molecular Cancer

    Article Title: A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers

    doi: 10.1186/s12943-024-01963-7

    Figure Lengend Snippet: Overview of FDA-approved ADC drugs

    Article Snippet: RemeGen , Third , Disitamab Vedotin (Aidixi) , HER2 , IgG1κ , Disitamab , mc‒VC‒PABC , MMAE , 4 , GC UC , Jun 8, 2021 (NMPA).

    Techniques: